.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Leukemia: A Review of Data from the ASH 2021 Meeting

Expert hematologist/oncologists come together to review key datasets in leukemia that were presented at the ASH 2021 Annual Meeting.

Sponsored in part by Takeda. Content independently developed by OncLive®

EP. 1: ASH 2021: Novel Therapy in Acute Lymphocytic Leukemia

January 31st 2022

Expert perspectives on clinical data readouts in acute lymphocytic leukemia from the ASH 2021 annual meeting.

EP. 2: ASH 2021: Key Data in Chronic Myeloid Leukemia

February 7th 2022

Shared insight on updates in the chronic myeloid leukemia treatment landscape following the ASH 2021 annual meeting.

EP. 3: ASH 2021: Updates in the Chronic Lymphocytic Leukemia Treatment Landscape

February 14th 2022

Following the ASH 2021 annual meeting, expert hematologist/oncologists discuss updates in chronic lymphocytic leukemia.